Business Context and Reporting Period
Company: John Wiley & Sons, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended January 31, 2006 (Fiscal Year 2006)
Business Overview: A global publisher of print and electronic products serving professional, scientific, technical, medical, and educational markets. Core segments include Professional/Trade, Scientific/Technical/Medical (STM), Higher Education, and international operations in Europe and Asia/Australia/Canada.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Jan 31, 2006 | 9 Months Ended Jan 31, 2006 |
|---|---|---|
| Revenue | $278,189 | $777,621 |
| Net Income | $40,949 | $95,810 |
| Operating Income | $54,101 | $129,728 |
| Diluted EPS | $0.69 | $1.59 |
| Cash from Operations | N/A | $167,404 |
| Long-Term Debt | $190,000 | $190,000 |
| Cash & Equivalents | $75,301 | $75,301 |
| Gross Margin | 67.2% | 67.3% |
| Operating Margin | 19.4% | 16.7% |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 8% year-over-year for the quarter ($278.2M vs. $258.4M) and 6% for the nine-month period ($777.6M vs. $732.4M). Growth was driven by the STM and Professional/Trade segments.
- Profitability: Net income rose 25% for the quarter and 21% for the nine-month period. However, adjusted net income (excluding tax benefits) grew only 4% and 3% respectively.
- Acquisitions: The company spent $29.1 million on acquisitions in the first nine months of 2006, compared to $13.7 million in the prior year. Notable acquisitions included Sybex (IT certification) and Dialysis & Transplantation.
- Debt Restructuring: The company entered a new $300 million revolving credit facility with Bank of America in November 2005, replacing a previous agreement with UBS AG. Outstanding debt was $190 million as of January 31, 2006.
- Share Repurchases: The company repurchased approximately 2.1 million shares during the nine-month period at an average price of $39.40, contributing to EPS growth.
Guidance, Outlook, and Risks
- Management Commentary: Management attributes revenue growth to strong performance in STM journals and Professional/Trade titles (e.g., "For Dummies" series, business books). Investments in technology (Wiley InterScience, WileyPLUS) and marketing are driving expense growth.
- Non-GAAP Adjustments: Reported earnings included significant one-time tax benefits: $6.8 million from the resolution of tax matters and $7.5 million from the reversal of a tax accrual on repatriated foreign dividends. Adjusted EPS for the nine months was $1.36 compared to reported $1.59.
- Capital Allocation: The company increased its quarterly dividend by 20% to $0.09 per share. Projected capital spending for fiscal 2006 is approximately $70 million for product development and $25 million for property/equipment.
- Risks:
- Market Risk: Exposure to interest rate fluctuations on $190 million of variable-rate debt and foreign exchange rates (Sterling, Euro, Asian currencies).
- Credit Risk: Concentration of revenue among top 10 book customers (approx. 25% of total revenue) and reliance on subscription agents (approx. 23% of revenue).
- Operational: Dependence on subscriber renewal rates and the financial stability of key online retailers and wholesalers.
Investor Verification Checklist
- Tax Benefit Sustainability: Verify the non-recurring nature of the $14.3 million in tax benefits included in net income to assess true operating performance.
- Acquisition Integration: Monitor the integration and revenue contribution of recent acquisitions (Sybex, Dialysis & Transplantation) against the $29.1 million investment.
- Debt Covenants: Review the restrictive covenants in the new $300 million credit facility regarding interest coverage ratios and limits on dividends/repurchases.
- Inventory Levels: Note the increase in inventory to $88.3 million (from $83.4 million at year-end 2005) and assess potential obsolescence risks in the book publishing sector.
- Stock-Based Compensation: Monitor the impact of the upcoming adoption of SFAS 123R in fiscal 2007, which will require expensing stock options, potentially reducing future reported earnings.